A pilot comparison study of four clinician‐rated atopic dermatitis severity scales
Male
Adolescent
610
32 Biomedical and Clinical Sciences
Dermatitis
Dermatology
anzsrc-for: 1103 Clinical Sciences
Severity of Illness Index
Atopic
Dermatitis, Atopic
03 medical and health sciences
anzsrc-for: 32 Biomedical and Clinical Sciences
0302 clinical medicine
Humans
Prospective Studies
3202 Clinical Sciences
Observer Variation
Eczema / Atopic Dermatitis
anzsrc-for: 1112 Oncology and Carcinogenesis
3. Good health
Quality of Life
Feasibility Studies
anzsrc-for: 3202 Clinical Sciences
Female
Self Report
DOI:
10.1111/bjd.13846
Publication Date:
2015-04-18T14:43:16Z
AUTHORS (9)
ABSTRACT
Background There are multiple severity outcome measures for atopic dermatitis (AD). is a need to compare the reliability of these measures. Objectives To inter-rater and intrarater objective Scoring Atopic Dermatitis (oSCORAD), Eczema Area Severity Index (EASI), Six Area, Sign (SASSAD) Three Item index (TIS); analyse correlation between quality-of-life instruments Patient-Orientated Measurement, Dermatology Life Quality Skindex-29. Methods Twelve patients with AD attended 1-day scoring exercise by five trained dermatology clinicians. Inter-rater were assessed using intraclass coefficient (ICC). Correlation clinician-rated patient-reported was analysed Spearman's rho. Results Regarding reliability, EASI SASSAD showed good reliabilities, ICCs 0·730 [95% confidence interval (CI) 0·500–0·900] 0·680 (95% CI 0·440–0·880), respectively. However, poor TIS oSCORAD, 0·497 0·233–0·785) 0·498 0·234–0·785), Separate body surface area (BSA) component analyses that oSCORAD BSA contributed its variations. excellent 0·886 0·744–0·952) 0·820 (0·614–0·923), respectively, while an ICC 0·720 0·424–0·878). 0·446 0·037–0·730). measures, only demonstrated moderate Skindex-29 (ρ = 0·611, P 0·035). Conclusions highest supporting it as optimal measure.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....